Carcinoma, Non-Small-Cell Lung
Showing 26 - 50 of >10,000
NSCLC Trial in Shanghai
Not yet recruiting
- Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 20, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tirelizumab;Chemotherapy monotherapy
- (no location specified)
Jul 27, 2023
NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Fairfax, Virginia
- +3 more
Jun 16, 2023
NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Amivantamab
- +6 more
- (no location specified)
Nov 7, 2023
NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))
Not yet recruiting
- Non-small Cell Lung Cancer
- Durvalumab
- +2 more
-
Iowa City, IowaUniversity of Iowa
Oct 10, 2023
Examination of Trends in Non-Small Cell Lung Cancer Patients'
Not yet recruiting
- Non-Small Cell Lung Cancer
- (no location specified)
Mar 10, 2023
Lung Cancer Trial (exercise)
Not yet recruiting
- Lung Cancer
- exercise
- (no location specified)
Jul 17, 2023
NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Toripalimab
- +2 more
-
Yangzhou, Jiangsu, ChinaPeople's hospital of northern jiangsu
Sep 26, 2023
Lung Cancer, Lung Tumor Malignant, NSCLC Trial in Amsterdam (Neelde Based Confocal Laser Endomicroscopy, Conventional diagnostic
Recruiting
- Lung Cancer
- +3 more
- Neelde Based Confocal Laser Endomicroscopy
- Conventional diagnostic bronchoscopy
-
Amsterdam, NetherlandsAmsterdam University Medical Centers
Oct 6, 2023
Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
-
Jinan, Shandong, ChinaShandong Cancer Hospital and Institute
Aug 8, 2023
NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- EGF-R Positive Non-Small Cell Lung Cancer
- Parimparib
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Jan 30, 2023
Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)
Not yet recruiting
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- disitamab vedotin
- (no location specified)
Aug 15, 2023
NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)
Not yet recruiting
- Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
- (no location specified)
Aug 27, 2023
NSCLC Trial in Guangzhou (Surufatinib,Toripalimab,Pemetrexed,Carboplatin/Cisplatin)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Guangzhou, Guang Dong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2022
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
NSCLC Trial in Suzhou (Envafolimab Injection)
Recruiting
- NSCLC
- Envafolimab Injection
-
Suzhou, Jiangsu, ChinaNorthern Jiangsu People's Hospital
Oct 29, 2023
Resectable Stage II-IIIB Driver Gene-negative Non-small Cell
Not yet recruiting
- NSCLC
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Aug 6, 2023
NSCLC Trial in Omaha (PLB1004)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Omaha, NebraskaNebraska Cancer Specialists
Sep 19, 2023
Identify Resected Non-small-cell Lung Cancer With High Risk of
Recruiting
- Non-small Cell Lung Cancer Stage IIIA
- Resected non small cell lung cancer
-
Toulouse, FranceJulien MAZIERES
Feb 8, 2023
PET-CT Predicting Segement Specific Lymph Nodes Metastasis
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Shanghai, ChinaShanghai Cancer Center
Jul 23, 2023
ALK Positive NSCLC Trial in Guangzhou (Loratinib)
Recruiting
- ALK Positive Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Perople's Hospital
Oct 19, 2023
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Oct 5, 2023